Northrop Grumman Developing PCR-Based Biodefense Dx System Under $9.6M BARDA Contract

Agilent Technologies, Columbia University, and others are collaborating on development of the system, which will be based on MassTag PCR.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.